Drug Trial Radar · NCT01658826
Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes
Last checked: Nov 19, 2026Latest source record: Apr 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
91
Actual
Start
Oct 2012
Primary completion
May 2013
Study completion Jul 2013
Sponsor
- Lead sponsor
- AiCuris Anti-infective Cures AGIndustry
- Sponsor type
- Industry
- Collaborators
- Medpace, Inc.
- First posted
- Aug 7, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study is to evaluate the safety and efficacy of "AIC316 (pritelivir)" 100 mg once daily compared to valacyclovir 500 mg once daily for the prevention of HSV-2 genital shedding.
Conditions
- Genital Herpes
Interventions
AIC316Drug
100 mg oral administration
ValacyclovirDrug
500 mg oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Within-subject Genital HSV Mucocutaneous Shedding RateTime frame: 28 days
- Overall Shedding RateTime frame: 28 days
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Indiana University School of Medicine, IU Infectious Diseases Research
Indianapolis, Indiana
Westover Heights Clinic
Portland, Oregon
University of Texas Health Science Centre, Center for Clincial Studies
Houston, Texas
University of Washington, Virology Research Clinic
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.